Definitive Historical Financial Ratios

DH Stock

USD 2.94 0.02 0.68%

Definitive Healthcare is recently reporting on over 105 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.75 will help investors to properly organize and evaluate Definitive Healthcare financial condition quickly.

Quick Ratio Current Ratio

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Definitive Financial Ratios Analysis

Definitive HealthcareFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Definitive Healthcare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Definitive financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Definitive Healthcare history.

Definitive Healthcare Financial Ratios Chart

As of now, Definitive Healthcare's Operating Cash Flow Per Share is increasing as compared to previous years. The Definitive Healthcare's current Capex To Depreciation is estimated to increase to 0.06, while Price To Sales Ratio is projected to decrease to 1.81.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Definitive Healthcare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Definitive Healthcare sales, a figure that is much harder to manipulate than other Definitive Healthcare Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Definitive Healthcare Corp dividend as a percentage of Definitive Healthcare stock price. Definitive Healthcare dividend yield is a measure of Definitive Healthcare stock productivity, which can be interpreted as interest rate earned on an Definitive Healthcare investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from Definitive Healthcare's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Definitive Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2022	2023	2024	2025 (projected)
Dividend Yield	0.0116	0.011	0.009862	0.0104
Price To Sales Ratio	4.99	4.46	1.9	1.81

Dividend Yield Price To Sales Ratio

Definitive Healthcare fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		-0.89	0.98	0.81	-0.3	-0.71	-0.93	-0.41	0.98	1.0	-0.86	0.66	0.73	0.74	-0.95	0.94	0.55	0.0	-0.89	1.0	0.71	-0.08	-0.41	0.99	-0.78	-0.17
Dividend Yield	-0.89		-0.94	-0.75	0.08	0.75	0.91	0.45	-0.94	-0.89	0.86	-0.69	-0.88	-0.71	0.95	-0.73	-0.57	-0.05	0.77	-0.93	-0.76	-0.13	0.28	-0.93	0.54	0.04
Ptb Ratio	0.98	-0.94		0.8	-0.17	-0.79	-0.97	-0.38	1.0	0.98	-0.92	0.74	0.78	0.8	-0.96	0.91	0.62	0.08	-0.83	1.0	0.79	-0.05	-0.31	1.0	-0.75	-0.17
Days Sales Outstanding	0.81	-0.75	0.8		-0.14	-0.61	-0.76	-0.2	0.8	0.81	-0.73	0.62	0.74	0.7	-0.79	0.74	0.3	0.23	-0.77	0.81	0.68	-0.19	-0.14	0.81	-0.79	-0.3
Book Value Per Share	-0.3	0.08	-0.17	-0.14		-0.43	-0.06	0.62	-0.17	-0.3	-0.21	0.5	-0.28	0.38	0.24	-0.25	0.51	0.61	0.53	-0.23	0.45	-0.39	0.74	-0.2	0.2	-0.51
Free Cash Flow Yield	-0.71	0.75	-0.79	-0.61	-0.43		0.92	0.01	-0.79	-0.71	0.96	-0.99	-0.41	-0.96	0.71	-0.7	-0.93	-0.33	0.46	-0.76	-0.98	0.29	-0.05	-0.77	0.58	0.48
Operating Cash Flow Per Share	-0.93	0.91	-0.97	-0.76	-0.06	0.92		0.24	-0.97	-0.93	0.99	-0.88	-0.65	-0.91	0.9	-0.89	-0.79	-0.19	0.72	-0.95	-0.91	0.17	0.18	-0.96	0.73	0.32
Capex To Depreciation	-0.41	0.45	-0.38	-0.2	0.62	0.01	0.24		-0.38	-0.42	0.08	0.1	-0.47	0.13	0.55	-0.17	0.06	0.85	0.69	-0.41	0.07	-0.75	0.92	-0.38	-0.05	-0.64
Pb Ratio	0.98	-0.94	1.0	0.8	-0.17	-0.79	-0.97	-0.38		0.98	-0.92	0.74	0.78	0.8	-0.96	0.91	0.62	0.08	-0.83	1.0	0.79	-0.05	-0.31	1.0	-0.75	-0.17
Ev To Sales	1.0	-0.89	0.98	0.81	-0.3	-0.71	-0.93	-0.42	0.98		-0.86	0.66	0.73	0.74	-0.95	0.94	0.55	-0.01	-0.89	1.0	0.71	-0.08	-0.42	0.99	-0.78	-0.18
Free Cash Flow Per Share	-0.86	0.86	-0.92	-0.73	-0.21	0.96	0.99	0.08	-0.92	-0.86		-0.94	-0.58	-0.96	0.83	-0.85	-0.84	-0.32	0.6	-0.89	-0.96	0.28	0.03	-0.91	0.72	0.43
Roic	0.66	-0.69	0.74	0.62	0.5	-0.99	-0.88	0.1	0.74	0.66	-0.94		0.35	0.98	-0.65	0.67	0.92	0.41	-0.4	0.71	0.99	-0.4	0.15	0.72	-0.58	-0.58
Inventory Turnover	0.73	-0.88	0.78	0.74	-0.28	-0.41	-0.65	-0.47	0.78	0.73	-0.58	0.35		0.41	-0.8	0.54	0.14	0.05	-0.69	0.76	0.45	0.31	-0.24	0.77	-0.45	0.21
Net Income Per Share	0.74	-0.71	0.8	0.7	0.38	-0.96	-0.91	0.13	0.8	0.74	-0.96	0.98	0.41		-0.7	0.78	0.87	0.47	-0.47	0.78	0.99	-0.49	0.15	0.79	-0.7	-0.64
Days Of Inventory On Hand	-0.95	0.95	-0.96	-0.79	0.24	0.71	0.9	0.55	-0.96	-0.95	0.83	-0.65	-0.8	-0.7		-0.8	-0.53	0.12	0.92	-0.97	-0.71	-0.06	0.47	-0.96	0.59	0.1
Payables Turnover	0.94	-0.73	0.91	0.74	-0.25	-0.7	-0.89	-0.17	0.91	0.94	-0.85	0.67	0.54	0.78	-0.8		0.58	0.17	-0.74	0.92	0.7	-0.3	-0.25	0.92	-0.91	-0.33
Average Inventory	0.55	-0.57	0.62	0.3	0.51	-0.93	-0.79	0.06	0.62	0.55	-0.84	0.92	0.14	0.87	-0.53	0.58		0.25	-0.27	0.59	0.88	-0.32	0.07	0.6	-0.38	-0.5
Capex To Revenue	0.0	-0.05	0.08	0.23	0.61	-0.33	-0.19	0.85	0.08	-0.01	-0.32	0.41	0.05	0.47	0.12	0.17	0.25		0.37	0.03	0.43	-0.66	0.91	0.07	-0.36	-0.62
Cash Per Share	-0.89	0.77	-0.83	-0.77	0.53	0.46	0.72	0.69	-0.83	-0.89	0.6	-0.4	-0.69	-0.47	0.92	-0.74	-0.27	0.37		-0.87	-0.46	-0.13	0.71	-0.85	0.57	-0.01
Pocfratio	1.0	-0.93	1.0	0.81	-0.23	-0.76	-0.95	-0.41	1.0	1.0	-0.89	0.71	0.76	0.78	-0.97	0.92	0.59	0.03	-0.87		0.76	-0.06	-0.37	1.0	-0.75	-0.18
Interest Coverage	0.71	-0.76	0.79	0.68	0.45	-0.98	-0.91	0.07	0.79	0.71	-0.96	0.99	0.45	0.99	-0.71	0.7	0.88	0.43	-0.46	0.76		-0.39	0.14	0.78	-0.6	-0.58
Payout Ratio	-0.08	-0.13	-0.05	-0.19	-0.39	0.29	0.17	-0.75	-0.05	-0.08	0.28	-0.4	0.31	-0.49	-0.06	-0.3	-0.32	-0.66	-0.13	-0.06	-0.39		-0.53	-0.07	0.39	0.96
Capex To Operating Cash Flow	-0.41	0.28	-0.31	-0.14	0.74	-0.05	0.18	0.92	-0.31	-0.42	0.03	0.15	-0.24	0.15	0.47	-0.25	0.07	0.91	0.71	-0.37	0.14	-0.53		-0.33	0.04	-0.47
Pfcf Ratio	0.99	-0.93	1.0	0.81	-0.2	-0.77	-0.96	-0.38	1.0	0.99	-0.91	0.72	0.77	0.79	-0.96	0.92	0.6	0.07	-0.85	1.0	0.78	-0.07	-0.33		-0.76	-0.19
Days Payables Outstanding	-0.78	0.54	-0.75	-0.79	0.2	0.58	0.73	-0.05	-0.75	-0.78	0.72	-0.58	-0.45	-0.7	0.59	-0.91	-0.38	-0.36	0.57	-0.75	-0.6	0.39	0.04	-0.76		0.37
Income Quality	-0.17	0.04	-0.17	-0.3	-0.51	0.48	0.32	-0.64	-0.17	-0.18	0.43	-0.58	0.21	-0.64	0.1	-0.33	-0.5	-0.62	-0.01	-0.18	-0.58	0.96	-0.47	-0.19	0.37

Click cells to compare fundamentals

Definitive Healthcare Account Relationship Matchups

Definitive Healthcare fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	35.5	15.96	4.99	4.46	1.9	1.81
Dividend Yield	7.0E-4	0.003065	0.0116	0.011	0.009862	0.0104
Ptb Ratio	3.51	3.04	1.17	1.3	0.79	0.75
Days Sales Outstanding	102.14	95.2	96.39	86.02	77.04	103.32
Book Value Per Share	12.32	15.49	14.71	10.63	5.21	4.95
Free Cash Flow Yield	0.005195	0.006969	0.0245	0.0341	0.12	0.13
Operating Cash Flow Per Share	0.24	0.26	0.35	0.37	0.5	0.52
Stock Based Compensation To Revenue	0.0148	0.0599	0.16	0.19	0.15	0.088
Capex To Depreciation	0.0234	0.11	0.15	0.0575	0.0518	0.0634
Pb Ratio	3.51	3.04	1.17	1.3	0.79	0.75
Ev To Sales	39.2	15.26	5.57	5.0	1.52	1.45
Free Cash Flow Per Share	0.22	0.19	0.27	0.34	0.5	0.52
Roic	(0.0114)	(0.009427)	(0.006527)	(0.19)	(0.71)	(0.68)
Net Income Per Share	(0.9)	(0.63)	(0.22)	(1.79)	(3.54)	(3.36)
Payables Turnover	5.38	8.75	10.8	8.2	5.09	4.83
Sales General And Administrative To Revenue	0.11	0.18	0.22	0.23	0.2	0.14
Research And Ddevelopement To Revenue	0.0935	0.11	0.16	0.17	0.14	0.1
Cash Per Share	0.26	3.99	3.28	2.73	2.49	1.7
Pocfratio	180.92	105.18	31.23	27.21	8.24	7.83
Interest Coverage	(0.29)	(0.72)	(2.75)	(21.69)	(47.91)	(45.51)
Payout Ratio	(0.0335)	(0.13)	(0.58)	(0.0607)	(0.0698)	(0.0733)
Capex To Operating Cash Flow	0.0601	0.27	0.23	0.0723	0.065	0.11
Pfcf Ratio	192.49	143.49	40.78	29.33	8.24	7.83
Days Payables Outstanding	67.83	41.72	33.81	44.49	71.78	37.06
Income Quality	(0.45)	(0.41)	(1.6)	(0.2)	(0.0984)	(0.1)
Roe	(0.0733)	(0.0702)	(0.0234)	(0.23)	(0.68)	(0.65)
Ev To Operating Cash Flow	199.75	100.55	34.86	30.54	6.6	6.27
Pe Ratio	(47.92)	(43.29)	(49.93)	(5.54)	(1.16)	(1.22)
Return On Tangible Assets	(1.19)	(0.12)	(0.0498)	(0.47)	(1.04)	(0.99)
Ev To Free Cash Flow	212.52	137.17	45.51	32.92	6.6	6.27
Earnings Yield	(0.0209)	(0.0231)	(0.02)	(0.18)	(0.86)	(0.82)
Intangibles To Total Assets	0.96	0.76	0.79	0.77	0.63	0.89
Net Debt To E B I T D A	9.73	(5.07)	5.5	(0.57)	0.17	0.16
Current Ratio	0.72	3.83	3.12	2.23	2.3	1.7
Tangible Book Value Per Share	(4.91)	(1.14)	(1.85)	(1.76)	(0.72)	(0.76)
Receivables Turnover	3.57	3.83	3.79	4.24	4.74	3.14
Shareholders Equity Per Share	12.32	9.0	9.42	7.64	5.21	9.48

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

How To Invest In Definitive

Details

Is Definitive Stock a good investment?

Details

What is Definitive Healthcare's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.54)

Revenue Per Share

2.162

Quarterly Revenue Growth

(0.06)

Return On Assets

(0)

Return On Equity

(0.65)

The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

Definitive Historical Financial Ratios

About Definitive Financial Ratios Analysis

Definitive Healthcare Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Definitive Healthcare fundamentals Correlations

Definitive Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Definitive Healthcare fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pocfratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Pocfratio	+ 1.0	Ptb Ratio
Pfcf Ratio	+ 1.0	Ptb Ratio
Pocfratio	+ 1.0	Pb Ratio

Roic	- 0.99	Free Cash Flow Yield
Interest Coverage	- 0.98	Free Cash Flow Yield
Pocfratio	- 0.97	Days Of Inventory On Hand
Pb Ratio	- 0.97	Operating Cash Flow Per Share
Operating Cash Flow Per Share	- 0.97	Ptb Ratio
Pfcf Ratio	- 0.96	Days Of Inventory On Hand